Terrie Curran, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,072 shares at $26.04 ($28K) on 2026-08-20, disclosed to the SEC on 2026-08-24.
Open-market sale of $28k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |
| PHAT | SELL | 2024-03-26 | $307K | — | Filing → |